Adjuvant therapy of kidney cell carcinoma;Adjuvante therapie des nierenzellkarzinoms

Urologe - Ausgabe B

Volumn 38, Issue 4, 1998, Pages 342-346

  Oberneder, R ^a   Siebels, M ^a   Hofstetter, A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALPHA INTERFERON; BCG VACCINE; DOXORUBICIN; HORMONE; INTERFERON; TUMOR VACCINE; VINBLASTINE;

CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; KIDNEY CARCINOMA; SHORT SURVEY;

EID: 0031672112     PISSN: 00421111     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001310050213     Document Type: Short Survey

References (25)

1. Adler A, Gillon G, Lurie H, Shahm J, Loven D, Shachter Y, Shani A, Servadio C, Stein JA (1987) Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormonoimmunoversus hormonotherapy. J Biol Response Mod 6: 610-624
2. Aref I, Bociek G, Salhani D (1997) Is post-operative radiation for renal cell carcinoma justified? Radiother Oncol 43: 155-157
3. Aso Y, Homma Y (1996) Adjuvant interfereon therapy for renal cell carcinoma. Akt Urol 27: 9-12
4. Finney R (1973) The value of radiotherapy in the treatment of hypernephroma - a clinical trial. Br J Ural 45: 258-269
5. Fischer C (1996) Leitlinien zur aktiv-spezifischen Immuntherapie beim Nierenzellkarzinom. Urol [B] 36: 253-255
6. Galligioni E, Francini M, Quaia M, Carbone A, Spada A, Sacco C, Favoro D, Santarosa M, Carmignani G, DiDonna D, Mazza G, Viggiano S, Fiaccavento G, DalBo V, Talamini R (1993) Randomized study of adjuvant immunotherapy with autologous tumor cells and BCG in renal cancer. Ann New York Acad Sci 690: 367-369
7. Goepel M, Rubben H (1991) Adjuvant therapy in renal cancer. World J Urol 9: 232-236
8. Guinan PD, Vogelzang NJ, Fremgen AM, Chmiel JS, Sylvester JL, Sener SF, Imperato JP and Members of the cancer incidence and end results committee (1995) Renal cell carcinoma: tumor size, stage and survival. J Urol 153: 901-903
9. Hinkel A, deRiese W, Alefelder J, Falkenberg FW, Senge T, Hertle H (1995) Active specific immunotherapy with an autologous virus-modified tumour cell vaccine in human renal cell carcinoma (RCC). Eur J Cancer 31A. 1719-1720
10. Hrushesky WJ, Murphy GP (1977) Current status of the therapy of advanced renal cell carcinoma. J Surg Oncol 9: 277-288
11. Johnsen JA, Hellsten S (1997) Lymphatogenous spread of renal cell carcinoma: an authopsy study. J Urol 157: 450-453
12. Juusela H, Malmio K, Alfthan O, Oravisto KJ (1977) Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol 11: 277-281
13. Kirchner HH, Anton P, Atzpodien J (1995) Adjuvant treatment of locally advanced renal cell cancer with autologous virus-modified tumor vakzines. World J Urol 13: 171-173
14. Kriegmair M, Oberneder R (1995) Die Tumorzellvakzinierung zur Behandlung des Nierenzellkarzinoms. Urol [A] 34: 204-207
15. Lopez-Hanninen E, Kirchner H, Atzpodien J (1996) Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients. J Ural 155: 19-25
16. Luiten RM, Coney LR, Fleuren GF, Warnaar SO, Litvinov SV (1996) Generation of chimeric bispecific G 250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma. Br J Cancer 74: 735-744
17. Masuda F, Nakada J, Kondo I, Furuta N (1992) Adjuvant chemotherapy with vinblastine, adriamycin and UFT for renal cell carcinoma. Cancer Chemother Pharmacol 30: 477-479
18. Migliari R, Muscas G, Solinas A, Melis M, Ionta MT, Massidda B, Usai E (1995) Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinomas? J Chemother 7: 240-245
19. Naito S, Kumazawa J, Omoto T, Iguchi A, Sagiyama K, Osada Y, Hiratsuka Y (1997) Postoperative UFT adjuvant and the risk factors for recurrence in renal cell carcinoma: a long-term follow-up study. Int J Urol 4: 8-12
20. Pizzocaro G, Piva L, DiFronzo G (1987) Adjuvant medroxyprogesteron acetate to radical nephrectomy in renal cell cancer: 5 years result of a prospective randomized study. J Urol 138: 1379-1381
21. Rabinovitch RA, Zelfsky MJ, Gaynor JJ, Fuks Z (1994) Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol 12: 206-212
22. Repmann R, Wagner S, Richter A (1997) Adjuvant therapy of renal cell carcinoma with active-specific-immunotherapy (ASI) using autologous tumor vaccine. Anticancer Res 17: 2879-2882
23. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, Buggisch P, Witte J et al (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal carcinoma. Lancet 343: 1177-1184
24. Wenderoth UK (1993) Adjuvant therapy of renal cell cancer (RCC) with interferon-alpha-2a. Preliminary results of the Delta-P-Study Group. J Urol 149: 447
25. Yagoda A (1989) Chemotherapy in renal cell carcinoma. Semin Urol 7. 199-206